![Øivind Enger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Øivind Enger
Director/Board Member at
Pluvia AS
Profile
Øivind Enger currently works at Novel Diagnostics AS, as Director, Pluvia AS, as Director, and Sarsia Management AS, as Partner from 2007.
Dr. Enger also formerly worked at Prophylix AS, as Vice Chairman, ScreenCancer AS, as Director, VoluSense AS, as Director, Enso AS, as Director, Caerus Consulting AS, as Director, Isentio AS, as Director, Sarsia Innovation AS, as Principal, and Blue Limit AS, as Principal.
Dr. Enger received his doctorate degree from the University of Bergen.
Øivind Enger active positions
| Companies | Position | Start |
|---|---|---|
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Management invests in companies located in Norway. The firm targets companies operating in the fields of life sciences, technology, energy and sustainability. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2007 |
Novel Diagnostics AS
 Novel Diagnostics AS BiotechnologyHealth Technology Provides biomedical research and diagnostic development services | Director/Board Member | - |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Director/Board Member | - |
Former positions of Øivind Enger
| Companies | Position | End |
|---|---|---|
Isentio AS
 Isentio AS Medical SpecialtiesHealth Technology Provides software and deoxyribonucleic acid analysis tools for pathogen identification | Director/Board Member | - |
Enso AS
 Enso AS Electrical ProductsProducer Manufacturing Provides technology for electricity to neutralize unwanted marine organisms in ballast water | Director/Board Member | - |
ScreenCancer AS
 ScreenCancer AS Medical/Nursing ServicesHealth Services Offers cancer screening and diagnostic program to the public | Director/Board Member | - |
Sarsia Innovation AS
 Sarsia Innovation AS Investment ManagersFinance Acts as Venture Capital Fund | Corporate Officer/Principal | - |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Director/Board Member | - |
Training of Øivind Enger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
University of Bergen
 University of Bergen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novel Diagnostics AS
Novel Diagnostics AS BiotechnologyHealth Technology Provides biomedical research and diagnostic development services | Health Technology |
Sarsia Innovation AS
Sarsia Innovation AS Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Management invests in companies located in Norway. The firm targets companies operating in the fields of life sciences, technology, energy and sustainability. It provides financing for early stage capital requirements. | Finance |
Blue Limit AS
 Blue Limit AS Agricultural Commodities/MillingProcess Industries Provides larvae feed for shrimp and mollusks | Process Industries |
ScreenCancer AS
ScreenCancer AS Medical/Nursing ServicesHealth Services Offers cancer screening and diagnostic program to the public | Health Services |
VoluSense AS
 VoluSense AS Medical SpecialtiesHealth Technology Provides medical equipment with focused on pulmonary health of preterm babies | Health Technology |
Enso AS
Enso AS Electrical ProductsProducer Manufacturing Provides technology for electricity to neutralize unwanted marine organisms in ballast water | Producer Manufacturing |
Caerus Consulting AS
 Caerus Consulting AS Pharmaceuticals: MajorHealth Technology Develops antibiotics to treat life threatening bacterial diseases | Health Technology |
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Provides prophylactic medicinal product for newborns | Health Technology |
Isentio AS
Isentio AS Medical SpecialtiesHealth Technology Provides software and deoxyribonucleic acid analysis tools for pathogen identification | Health Technology |
Pluvia AS
Pluvia AS Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology | Commercial Services |
- Stock Market
- Insiders
- Øivind Enger
